Literature DB >> 11801728

Dissection of HEF1-dependent functions in motility and transcriptional regulation.

Sarah J Fashena1, Margret B Einarson, Geraldine M O'Neill, Christos Patriotis, Erica A Golemis.   

Abstract

Cas-family proteins have been implicated as signaling intermediaries in diverse processes including cellular attachment, motility, growth factor response, apoptosis and oncogenic transformation. The three defined Cas-family members (p130Cas, HEF1/Cas-L and Efs/Sin) are subject to multiple forms of regulation (including cell-cycle- and cell-attachment-mediated post-translational modification and cleavage) that complicate elucidation of the function of specific Cas proteins in defined biological processes. To explore the biological role of HEF1 further, we have developed a series of cell lines in which HEF1 production is regulated by an inducible promoter. In this system, HEF1 production rapidly induces changes in cellular morphology and motility, enhancing cell speed and haptotaxis towards fibronectin in a process partially dependent on intact ERK and p38 MAPK signaling pathways. Finally, cDNA expression array analysis and subsequent studies indicate that HEF1 production increases levels of mRNA transcripts encoding proteins that are associated with motility, cell transformation and invasiveness, including several metalloproteinases, MLCK, p160ROCK and ErbB2. Upregulation of such proteins suggests mechanisms through which misregulation of HEF1 may be involved in cancer progression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11801728     DOI: 10.1242/jcs.115.1.99

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  40 in total

1.  Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle.

Authors:  Disha Dadke; Michael Jarnik; Elena N Pugacheva; Mahendra K Singh; Erica A Golemis
Journal:  Mol Biol Cell       Date:  2006-01-04       Impact factor: 4.138

2.  NEDD9 depletion leads to MMP14 inactivation by TIMP2 and prevents invasion and metastasis.

Authors:  Sarah L McLaughlin; Ryan J Ice; Anuradha Rajulapati; Polina Y Kozyulina; Ryan H Livengood; Varvara K Kozyreva; Yuriy V Loskutov; Mark V Culp; Scott A Weed; Alexey V Ivanov; Elena N Pugacheva
Journal:  Mol Cancer Res       Date:  2013-11-07       Impact factor: 5.852

3.  HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.

Authors:  Y Li; J H Bavarva; Z Wang; J Guo; C Qian; S N Thibodeau; E A Golemis; W Liu
Journal:  Oncogene       Date:  2011-02-14       Impact factor: 9.867

4.  Expression and clinical significance of NEDD9 in lung tissues.

Authors:  Jing-Xia Chang; Feng Gao; Guo-Qiang Zhao; Guo-Jun Zhang
Journal:  Med Oncol       Date:  2012-03-24       Impact factor: 3.064

5.  Human enhancer of invasion-cluster, a coiled-coil protein required for passage through mitosis.

Authors:  Margret B Einarson; Edna Cukierman; Duane A Compton; Erica A Golemis
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

Review 6.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

7.  NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.

Authors:  Rongfeng Shi; Lei Wang; Tao Wang; Junfei Xu; Feiran Wang; Meirong Xu
Journal:  Med Oncol       Date:  2014-01-28       Impact factor: 3.064

8.  NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA/HDAC6-dependent manner.

Authors:  Varvara K Kozyreva; Sarah L McLaughlin; Ryan H Livengood; Robin A Calkins; Laura C Kelley; Anuradha Rajulapati; Ryan J Ice; Matthew B Smolkin; Scott A Weed; Elena N Pugacheva
Journal:  Mol Cancer Res       Date:  2014-02-26       Impact factor: 5.852

Review 9.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

10.  High expression of NEDD9 predicts adverse outcomes of colorectal cancer patients.

Authors:  Peng Li; Houmin Zhou; Xinhong Zhu; Guiliang Ma; Chao Liu; Bin Lin; Weizheng Mao
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.